Decline depth
-29.1%
From rolling 252-day high of $92.08, 45d ago.
Past the 20% Watch threshold.
Amber List
DBDDiebold Nixdorf, Incorporated
-29.1%
from rolling 252-day high of $92.08 set 2026-07-27 · 45d ago
Current
$65.27
Decline depth
-29.1%
Decline σ
7.1σ
TFC
0/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$DBD landed on the list 2026-08-24, down 25.3% from its 52-week high that day — now down -29.1%.
That's 3.4 percentage points deeper than the day it joined.
From the 52-week high as of 2026-08-24 to today. Split-adjusted. Observed, not a forecast.
Structural break signals
DBD qualifies for the Amber List on decline depth.
Time-frame continuity
0/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
7.1σ
Drop over the last 20 bars in units of daily volatility (1.71%/day).
Past the ≥6σ Amber threshold.
The structural read
What price action says about DBD.
DBD qualifies for the Amber List on decline depth — down -29.1% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 7.1σ over 20 bars.
Questions about DBD
What people ask.
Why is DBD on Broken Stocks?
DBD qualifies for the Amber List on decline depth. It is down -29.1% from its rolling 252-day high of $92.08, set on 2026-07-27 — 45d ago.
Is DBD a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. DBD is down -29.1% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is DBD a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is DBD trading inside its 52-week range?
At $65.27, DBD sits 1.0% of the way from its 52-week low ($65.00) to its 52-week high ($92.08). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has DBD been declining?
The current 29.1% decline accrued over 45d, which annualizes to roughly -236.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.